SG Americas Securities LLC Sells 65,597 Shares of CVS Health Co. (NYSE:CVS)

SG Americas Securities LLC reduced its position in shares of CVS Health Co. (NYSE:CVSFree Report) by 58.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 45,970 shares of the pharmacy operator’s stock after selling 65,597 shares during the period. SG Americas Securities LLC’s holdings in CVS Health were worth $3,630,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Moneta Group Investment Advisors LLC increased its position in CVS Health by 103,371.0% during the 4th quarter. Moneta Group Investment Advisors LLC now owns 15,547,559 shares of the pharmacy operator’s stock valued at $1,448,877,000 after purchasing an additional 15,532,533 shares during the period. Norges Bank acquired a new stake in CVS Health during the 4th quarter valued at approximately $1,425,416,000. FMR LLC increased its position in CVS Health by 29.1% during the 3rd quarter. FMR LLC now owns 27,487,238 shares of the pharmacy operator’s stock valued at $1,919,159,000 after purchasing an additional 6,194,441 shares during the period. Morgan Stanley increased its position in CVS Health by 10.9% during the 4th quarter. Morgan Stanley now owns 33,576,388 shares of the pharmacy operator’s stock valued at $3,128,984,000 after purchasing an additional 3,311,928 shares during the period. Finally, Barclays PLC increased its position in CVS Health by 97.8% during the 2nd quarter. Barclays PLC now owns 5,483,154 shares of the pharmacy operator’s stock valued at $379,052,000 after purchasing an additional 2,711,102 shares during the period. 80.66% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of research firms have issued reports on CVS. SVB Leerink began coverage on CVS Health in a report on Monday, February 26th. They set an “outperform” rating and a $88.00 price target on the stock. Royal Bank of Canada cut their price target on CVS Health from $86.00 to $84.00 and set an “outperform” rating on the stock in a report on Thursday, February 8th. StockNews.com cut CVS Health from a “buy” rating to a “hold” rating in a report on Thursday, February 15th. Piper Sandler increased their target price on CVS Health from $93.00 to $94.00 and gave the stock an “overweight” rating in a report on Friday, March 15th. Finally, TD Cowen cut their target price on CVS Health from $102.00 to $99.00 and set an “outperform” rating on the stock in a report on Monday, December 11th. Four equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $90.21.

View Our Latest Analysis on CVS

Insider Activity

In other news, EVP Prem S. Shah sold 29,473 shares of CVS Health stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the completion of the sale, the executive vice president now owns 39,765 shares in the company, valued at approximately $3,059,916.75. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.25% of the company’s stock.

CVS Health Trading Up 0.7 %

Shares of CVS Health stock opened at $79.00 on Tuesday. CVS Health Co. has a 1 year low of $64.41 and a 1 year high of $83.25. The firm has a market cap of $99.41 billion, a PE ratio of 12.23, a P/E/G ratio of 1.04 and a beta of 0.51. The stock has a fifty day moving average price of $75.53 and a 200-day moving average price of $73.23. The company has a debt-to-equity ratio of 0.77, a current ratio of 0.86 and a quick ratio of 0.63.

CVS Health (NYSE:CVSGet Free Report) last issued its earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 EPS for the quarter, topping the consensus estimate of $2.01 by $0.11. The business had revenue of $93.81 billion during the quarter, compared to the consensus estimate of $90.58 billion. CVS Health had a return on equity of 15.25% and a net margin of 2.33%. The firm’s revenue was up 11.9% compared to the same quarter last year. During the same quarter last year, the company earned $1.99 EPS. Equities research analysts anticipate that CVS Health Co. will post 8.33 EPS for the current year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 1st. Stockholders of record on Monday, April 22nd will be given a dividend of $0.665 per share. The ex-dividend date is Friday, April 19th. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.37%. CVS Health’s dividend payout ratio (DPR) is presently 41.18%.

About CVS Health

(Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Featured Articles

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVSFree Report).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.